These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 32861197)

  • 41. Altered Gut Microbiota and Its Clinical Relevance in Mild Cognitive Impairment and Alzheimer's Disease: Shanghai Aging Study and Shanghai Memory Study.
    Zhu Z; Ma X; Wu J; Xiao Z; Wu W; Ding S; Zheng L; Liang X; Luo J; Ding D; Zhao Q
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of
    Ueda A; Shinkai S; Shiroma H; Taniguchi Y; Tsuchida S; Kariya T; Kawahara T; Kobayashi Y; Kohda N; Ushida K; Kitamura A; Yamada T
    Cell Rep Med; 2021 Sep; 2(9):100398. PubMed ID: 34622235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unique trans-kingdom microbiome structural and functional signatures predict cognitive decline in older adults.
    Chaudhari DS; Jain S; Yata VK; Mishra SP; Kumar A; Fraser A; Kociolek J; Dangiolo M; Smith A; Golden A; Masternak MM; Holland P; Agronin M; White-Williams C; Arikawa AY; Labyak CA; Yadav H
    Geroscience; 2023 Oct; 45(5):2819-2834. PubMed ID: 37213047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice.
    Maldonado Weng J; Parikh I; Naqib A; York J; Green SJ; Estus S; LaDu MJ
    Mol Neurodegener; 2019 Dec; 14(1):47. PubMed ID: 31861986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gut microbiome alterations in preclinical Alzheimer's disease.
    Jung JH; Kim G; Byun MS; Lee JH; Yi D; Park H; Lee DY;
    PLoS One; 2022; 17(11):e0278276. PubMed ID: 36445883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Chen TB; Lai YH; Ke TL; Chen JP; Lee YJ; Lin SY; Lin PC; Wang PN; Cheng IH
    Dement Geriatr Cogn Disord; 2019; 48(3-4):180-195. PubMed ID: 31991443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ketogenic therapies in Parkinson's disease, Alzheimer's disease, and mild cognitive impairment: An integrative review.
    Price S; Ruppar TM
    Appl Nurs Res; 2023 Dec; 74():151745. PubMed ID: 38007248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropsychiatric Symptoms and In Vivo Alzheimer's Biomarkers in Mild Cognitive Impairment.
    Spampinato MV; Ulber JL; Fayyaz H; Sullivan A; Collins HR;
    J Alzheimers Dis; 2023; 96(4):1827-1836. PubMed ID: 38007644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fungal diversity in the gut microbiome of young South African children.
    Nel Van Zyl K; Whitelaw AC; Hesseling AC; Seddon JA; Demers AM; Newton-Foot M
    BMC Microbiol; 2022 Aug; 22(1):201. PubMed ID: 35978282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Role of Apolipoprotein E ε4 in Early and Late Mild Cognitive Impairment.
    Luo Y; Tan L; Therriault J; Zhang H; Gao Y;
    Eur Neurol; 2021; 84(6):472-480. PubMed ID: 34340229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TNF receptors are associated with tau pathology and conversion to Alzheimer's dementia in subjects with mild cognitive impairment.
    Zhao A; Li Y; Deng Y;
    Neurosci Lett; 2020 Nov; 738():135392. PubMed ID: 32947003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Microbiota-Gut-Brain Axis in Alzheimer's Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions.
    Murray ER; Kemp M; Nguyen TT
    Arch Clin Neuropsychol; 2022 Feb; 37(3):595-607. PubMed ID: 35202456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated Inflammatory Markers and Arterial Stiffening Exacerbate Tau but Not Amyloid Pathology in Older Adults with Mild Cognitive Impairment.
    Clark AL; Weigand AJ; Thomas KR; Solders SK; Delano-Wood L; Bondi MW; Bernier RA; Sundermann EE; Banks SJ; Bangen KJ;
    J Alzheimers Dis; 2021; 80(4):1451-1463. PubMed ID: 33682714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD.
    Sanfilippo C; Forlenza O; Zetterberg H; Blennow K
    J Neural Transm (Vienna); 2016 Dec; 123(12):1443-1447. PubMed ID: 27531278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease.
    Duits FH; Brinkmalm G; Teunissen CE; Brinkmalm A; Scheltens P; Van der Flier WM; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2018 Jan; 10(1):5. PubMed ID: 29370833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer's disease: a potential early sign of AD.
    Goikolea J; Gerenu G; Daniilidou M; Mangialasche F; Mecocci P; Ngandu T; Rinne J; Solomon A; Kivipelto M; Cedazo-Minguez A; Sandebring-Matton A; Maioli S
    Alzheimers Res Ther; 2022 Feb; 14(1):37. PubMed ID: 35209952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-β and Tau Levels in the Continuum of Alzheimer's Disease.
    García-Escobar G; Puig-Pijoan A; Puente-Periz V; Fernández-Lebrero A; María Manero R; Navalpotro-Gómez I; Suárez-Calvet M; Grau-Rivera O; Contador-Muñana J; Cascales-Lahoz D; Duran-Jordà X; Boltes N; Pont-Sunyer MC; Ortiz-Gil J; Carrillo-Molina S; López-Villegas MD; Abellán-Vidal MT; Martínez-Casamitjana MI; Hernández-Sánchez JJ; Padrós-Fluvià A; Peña-Casanova J; Sánchez-Benavides G
    J Alzheimers Dis; 2023; 92(4):1303-1321. PubMed ID: 37038810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.